DITPA

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameDITPA
Drug Alias Name3,5-diiodothyropropionic acid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor agonists
TargetsThyroid hormone receptor
Therapy Area/IndicationsHypercholesterolemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZarion Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins UniversityTitan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A